MDMA and Their Analogs as Therapeutics for Mental Disorder and Response Predictor.
ACS Medicinal Chemistry Letters September 7, 2022 DOI: 10.1021/acsmedchemlett.2c00389 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | MDMA |
Abstract
Provided herein are MDMA and their analogs for the potential psychotherapy-assisted treatment of alcohol use disorder (AUD), post-traumatic stress disorder (PTSD), and a method of predicting dosing and patient response.
Citations in the library
Cited by 2
- Methylenedioxymethamphetamine is a connectogen with empathogenic, entactogenic, and still further connective properties: It is time to reconcile “the great entactogen—empathogen debate” Journal of Psychopharmacology July 28, 2024
- Psychedelics and Autism Therapy: A Review of Current Research and Future Directions Current Issues in Molecular Biology April 18, 2026
Cites 6
- MDMA‐Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta‐Analysis The Journal of Clinical Pharmacology October 28, 2021
- Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review Psychopharmacology March 7, 2022
- Entactogens: How the Name for a Novel Class of Psychoactive Agents Originated Frontiers in Psychiatry March 25, 2022
- Challenges in translational research: MDMA in the laboratory versus therapeutic settings. Journal of Psychopharmacology March 1, 2022
- Review of potential psychedelic treatments for PTSD. Journal of the Neurological Sciences August 15, 2022
and 1 more in the library